Literature DB >> 17402966

Role of activity-dependent mechanisms in the control of dopaminergic neuron survival.

Patrick P Michel1, Daniel Alvarez-Fischer, Serge Guerreiro, Audrey Hild, Andreas Hartmann, Etienne C Hirsch.   

Abstract

Dopaminergic neurons that constitute the nigrostriatal pathway are characterized by singular electrical properties that allow them to discharge in vivo spontaneously in a spectrum of patterns ranging from pacemaker to random and bursting modes. These electrophysiological features allow dopaminergic neurons to optimize the release of dopamine in their terminal fields. However, there is emerging evidence indicating that electrical activity might also participate in the control of dopaminergic neuron survival, not only during development, but also in the adult brain, thus raising the possibility that alterations in ionic currents could contribute actively to the demise of these neurons in Parkinson disease. This review focuses on the mechanisms by which activity-dependent mechanisms might modulate dopaminergic cell survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17402966     DOI: 10.1111/j.1471-4159.2006.04424.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.

Authors:  Bruno A Benítez; Helen M Belálcazar; Agustín Anastasía; Daniel T Mamah; Charles F Zorumski; Daniel H Mascó; Daniel G Herrera; Gabriel A de Erausquin
Journal:  Neuropharmacology       Date:  2010-10-31       Impact factor: 5.250

2.  Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Laurel Macey; Lauren T Brown; Anna M Krichevsky; Susan L Andersen; Robert M Stephens; Francine M Benes; Kai C Sonntag
Journal:  Brain       Date:  2008-12-03       Impact factor: 13.501

3.  Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Robert Stephens; Kai C Sonntag
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

Review 4.  Dopamine and aging: intersecting facets.

Authors:  C David Rollo
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

Review 5.  Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.

Authors:  Johanna Duda; Christina Pötschke; Birgit Liss
Journal:  J Neurochem       Date:  2016-03-23       Impact factor: 5.372

Review 6.  On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease.

Authors:  Nicolas Giguère; Samuel Burke Nanni; Louis-Eric Trudeau
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

7.  Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity.

Authors:  Bernardo Stutz; Carole Nasrallah; Mariana Nigro; Daniel Curry; Zhong-Wu Liu; Xiao-Bing Gao; John D Elsworth; Liat Mintz; Tamas L Horvath
Journal:  Mol Metab       Date:  2019-02-21       Impact factor: 7.422

Review 8.  Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease.

Authors:  Liang Sun; Huafeng Wei
Journal:  Cell Mol Neurobiol       Date:  2020-08-24       Impact factor: 5.046

9.  Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model.

Authors:  Daniel Alvarez-Fischer; Carmen Noelker; Franca Vulinović; Anne Grünewald; Caroline Chevarin; Christine Klein; Wolfgang H Oertel; Etienne C Hirsch; Patrick P Michel; Andreas Hartmann
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

Review 10.  Caffeine and Clinical Outcomes in Premature Neonates.

Authors:  Vasantha H S Kumar; Steven E Lipshultz
Journal:  Children (Basel)       Date:  2019-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.